Christopher Frey is an Associate Principal Scientist at Merck, where they focus on analytical assay development for monoclonal antibody characterization. With extensive experience in biotechnology and research, they previously worked as a Senior Scientist at Merck, where they evaluated critical quality attributes of monoclonal antibodies and led various method development projects. Their earlier roles include Research Scientist at Transgenomic and Aseptic Technician at Pfizer Animal Health, demonstrating a strong foundation in both analytical and laboratory techniques. Christopher holds a Ph.D. in Chemistry from the University of Nebraska-Lincoln and a B.S. in Chemistry and Biology from Doane College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices